Novartis to acquire kidney disease drug maker Regulus Therapeutics for up to 1.7 billion Ruchika Sharma1 May 2025 12:30 PM ISTTransaction includes USD 0.8 billion upfront with a potential additional USD 0.9 billion payment upon the achievement of a future regulatory...
Strides Pharma Science Singapore arm secures USFDA nod for nonsteroidal anti-inflammatory drug Ruchika Sharma1 May 2025 11:35 AM ISTBangalore: Strides Pharma Global Pte. Limited, a step-down wholly owned subsidiary of Strides Pharma Science Limited in Singapore, has received...
Govt Issues Export Guidelines for Doxycycline 100 mg Dispersible Tablets Farhat Nasim30 April 2025 7:29 PM ISTNew Delhi: The Directorate General of Foreign Trade (DGFT), under the Ministry of Commerce and Industry, has issued Public Notice No. 03/2025-26 dated...
Gland Pharma bags USFDA nod for glaucoma drug Ruchika Sharma30 April 2025 4:40 PM ISTHyderabad: Gland Pharma Limited, a generic injectable & ophthalmic focused pharmaceutical company, has announced that the company has...
USFDA approves AbbVie giant cell arteritis drug Rinvoq in adults Ruchika Sharma30 April 2025 4:30 PM ISTNorth Chicago, Ill.: AbbVie has received approval from the U.S. Food and Drug Administration (FDA) for RINVOQ (upadacitinib), 15 mg, once daily,...
Strides Pharma buys four approved ANDAs from Nostrum Labs for over Rs 17 crore Ruchika Sharma30 April 2025 3:28 PM ISTBengaluru: Strides Pharma Inc., a Step-down wholly-owned subsidiary of Strides Pharma Science Limited in the US, has acquired four...
USFDA issues EIR for Alembic Pharma Panelav facility Ruchika Sharma30 April 2025 2:46 PM ISTVadodara: Alembic Pharma, an Indian multinational pharmaceutical company, has announced that the Company has received an Establishment...
Fixed duration Calquence based regimens recommended for EMA Committee for chronic lymphocytic leukaemia: AstraZenaca Ruchika Sharma30 April 2025 1:30 PM ISTAstraZeneca has announced that a fixed-duration regimen of Calquence (acalabrutinib) in combination with venetoclax, with or without...
AstraZeneca discontinues Phase 3 trial of Truqap in metastatic castration-resistant prostate cancer Ruchika Sharma30 April 2025 12:14 PM ISTTruqap was discovered by AstraZeneca subsequent to a collaboration with Astex Therapeutics.
Zydus Lifesciences wins USFDA okay for cholesterol-lowering drug Niacin Extended Release Ruchika Sharma30 April 2025 11:15 AM ISTAhmedabad: Zydus Lifesciences Limited has announced that the company has received final approval from the United States Food and Drug...
CDSCO panel grants clearance to Morepen Labs to conduct BE studies for fatty liver disease drug Resmetirom Ruchika Sharma29 April 2025 4:11 PM ISTGurugram: Morepen Laboratories Ltd. has received clearance from the Subject Expert Committee (SEC) of Central Drugs Standard Control...
Morepen Labs names Kushal Suri as President - International Growth Ruchika Sharma29 April 2025 2:30 PM ISTBaddi: Morepen Labs has announced the redesignation of Senior Management Personnel, Kushal Suri, as President - International Growth. He...
